SLNO FY 2016 Earnings — Soleno Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SLNOSoleno Therapeutics, Inc.

$2B

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M+274.3% YoY

Gross Profit

-$58,518-4.0% margin

Operating Income

-$14M-938.1% margin

Net Income

-$12M-831.6% margin

EPS (Diluted)

$-58.35

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$14M

Stock-Based Comp.

$871,270

Balance Sheet

Total Assets

$6M

Total Liabilities

$2M

Stockholders' Equity

$3M

Cash & Equivalents

$3M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$387,555	+274.3%
Gross Profit	-$58,518	$34,872	-267.8%
Operating Income	-$14M	-$12M	-11.9%
Net Income	-$12M	-$16M	+24.2%